Phase II study of KX2-391 ointment 1%, a novel field treatment for actinic keratosis, based on Src/tubulin polymerization inhibition

التفاصيل البيبلوغرافية
العنوان: Phase II study of KX2-391 ointment 1%, a novel field treatment for actinic keratosis, based on Src/tubulin polymerization inhibition
المؤلفون: Michael Jarratt, Jane Fang, Seth Forman, David M. Cutler, Rudolf Kwan, Steven Kempers, Hui Wang
المصدر: Journal of the American Academy of Dermatology. 79:AB220
بيانات النشر: Elsevier BV, 2018.
سنة النشر: 2018
مصطلحات موضوعية: Field (physics), business.industry, Actinic keratosis, Dermatology, medicine.disease, 03 medical and health sciences, 0302 clinical medicine, 030220 oncology & carcinogenesis, Biophysics, medicine, Tubulin polymerization, business, 030217 neurology & neurosurgery, Proto-oncogene tyrosine-protein kinase Src
تدمد: 0190-9622
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::748e2b02527127751f73e242e0466be2
https://doi.org/10.1016/j.jaad.2018.05.881
حقوق: CLOSED
رقم الأكسشن: edsair.doi...........748e2b02527127751f73e242e0466be2
قاعدة البيانات: OpenAIRE